Human calcitonin
含有 Human calcitonin 的品牌、食物注意事项以及最重要的药物相互作用。
品牌
0未找到该活性成分的已注册品牌。
食物注意事项
0该活性成分暂无已收录的食物注意事项。
最重要的相互作用
前 10 项,共 13 项当 Human calcitonin 与 Alendronic acid 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Alendronic acid.
当 Human calcitonin 与 Clodronic acid 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Clodronic acid.
当 Human calcitonin 与 Etidronic acid 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Etidronic acid.
Human calcitonin 可能加快 Lithium carbonate 的排泄速度,从而可能导致血药浓度降低并使疗效降低。
专业视图
Human calcitonin may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.
Human calcitonin 可能加快 Lithium citrate 的排泄速度,从而可能导致血药浓度降低并使疗效降低。
专业视图
Human calcitonin may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.
Human calcitonin 可能加快 Lithium hydroxide 的排泄速度,从而可能导致血药浓度降低并使疗效降低。
专业视图
Human calcitonin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
当 Magnesium 与 Human calcitonin 联合使用时,Magnesium 的血药浓度可能升高。
专业视图
The serum concentration of Magnesium can be increased when it is combined with Human calcitonin.
当 Human calcitonin 与 Ibandronate 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Ibandronate.
当 Human calcitonin 与 Incadronic acid 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Incadronic acid.
当 Human calcitonin 与 Pamidronic acid 联合使用时,发生 低钙血症 的风险或严重程度可能增加。
专业视图
The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Pamidronic acid.